Tumor-Suppressive miR-192-5p Has Prognostic Value in Pancreatic Ductal Adenocarcinoma.

epithelial-to-mesenchymal transition exosomes liquid biopsy microRNA-192-5p pancreatic ductal adenocarcinoma zinc finger E-box-binding homeobox 2

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
25 Jun 2020
Historique:
received: 10 06 2020
revised: 20 06 2020
accepted: 22 06 2020
entrez: 8 7 2020
pubmed: 8 7 2020
medline: 8 7 2020
Statut: epublish

Résumé

Pancreatic ductal adenocarcinoma (PDAC) is characterized by fast tumor progression and diagnosis at advanced, inoperable stages. Previous studies could demonstrate an involvement of miR-192-5p in epigenetic regulation of visceral carcinomas. Due to contradictory results, however, the clinical utility of miR-192-5p in PDAC has yet to be determined. MiR-192-5p expression was analyzed by RT-qRT-PCR in human PDAC and benign tissue (

Identifiants

pubmed: 32630552
pii: cancers12061693
doi: 10.3390/cancers12061693
pmc: PMC7352756
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Nat Rev Immunol. 2002 Aug;2(8):569-79
pubmed: 12154376
Cancer Med. 2019 Jun;8(6):2810-2822
pubmed: 31006985
World J Surg Oncol. 2013 Sep 04;11:219
pubmed: 24007214
Nat Rev Drug Discov. 2017 Mar;16(3):203-222
pubmed: 28209991
Cancers (Basel). 2020 Jan 13;12(1):
pubmed: 31941049
J Cancer. 2019 Jan 29;10(4):1039-1051
pubmed: 30854110
Oncotarget. 2017 Aug 18;8(44):77028-77040
pubmed: 29100367
Oncol Rep. 2013 Jul;30(1):276-84
pubmed: 23612862
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Kaohsiung J Med Sci. 2019 Jan;35(1):17-23
pubmed: 30844143
Cancer Lett. 2017 May 1;393:86-93
pubmed: 28232049
World J Surg Oncol. 2020 Feb 3;18(1):29
pubmed: 32013999
Gene. 2018 Oct 5;673:181-193
pubmed: 29913239
JAMA. 2013 Oct 9;310(14):1473-81
pubmed: 24104372
Eur Rev Med Pharmacol Sci. 2020 Feb;24(4):1794-1806
pubmed: 32141548
Biomed Rep. 2020 Jan;12(1):30-34
pubmed: 31839947
Nucleic Acids Res. 2005 Nov 24;33(20):6566-78
pubmed: 16314317
Oncol Rep. 2014 Mar;31(3):1157-64
pubmed: 24398877
Oncol Lett. 2018 May;15(5):6947-6956
pubmed: 29731868
N Engl J Med. 2011 May 12;364(19):1817-25
pubmed: 21561347
Cancer Med. 2017 Jan;6(1):109-119
pubmed: 28035762
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Mol Med Rep. 2019 Mar;19(3):1753-1760
pubmed: 30628692
Appl Immunohistochem Mol Morphol. 2017 Apr;25(4):251-260
pubmed: 26580097
Biochim Biophys Acta Rev Cancer. 2019 Jan;1871(1):75-84
pubmed: 30419313
Curr Probl Cancer. 2020 Jan 23;:100540
pubmed: 32007320
Int J Cancer. 2015 Jun 1;136(11):2616-27
pubmed: 25388097
Nat Rev Drug Discov. 2017 Mar;16(3):167-179
pubmed: 27444227
Adv Drug Deliv Rev. 2015 Jan;81:16-33
pubmed: 25453266
Nat Cell Biol. 2017 May;19(5):518-529
pubmed: 28414315
BMC Cancer. 2018 Jan 31;18(1):116
pubmed: 29385987
J Hepatobiliary Pancreat Sci. 2018 Feb;25(2):155-161
pubmed: 29130611
Cancers (Basel). 2019 Feb 11;11(2):
pubmed: 30754729
Oncol Rep. 2015 Nov;34(5):2782-9
pubmed: 26351877
Gastroenterology. 2014 Jan;146(1):268-77.e18
pubmed: 24120476
Oncol Rep. 2019 Nov;42(5):1667-1676
pubmed: 31485620
Cancers (Basel). 2018 Sep 13;10(9):
pubmed: 30217058
Sci Rep. 2019 Dec 23;9(1):19619
pubmed: 31873114
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Oncogene. 2014 Nov 13;33(46):5332-40
pubmed: 24213572
N Engl J Med. 2010 Apr 29;362(17):1605-17
pubmed: 20427809
N Engl J Med. 2018 Dec 20;379(25):2395-2406
pubmed: 30575490
Nat Rev Cancer. 2015 Jun;15(6):321-33
pubmed: 25998712
PLoS One. 2015 Nov 25;10(11):e0143755
pubmed: 26606261
Int J Cancer. 2016 Nov 15;139(10):2312-24
pubmed: 27464352
JAMA. 2014 Jan 22-29;311(4):392-404
pubmed: 24449318
Tumour Biol. 2013 Dec;34(6):3279-92
pubmed: 23949878
Hum Cell. 2018 Jul;31(3):210-219
pubmed: 29536411
Med Princ Pract. 2019;28(2):124-132
pubmed: 30544100
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Tumour Biol. 2017 Mar;39(3):1010428317695018
pubmed: 28351309
Cancer Res. 2016 Jul 15;76(14):4149-59
pubmed: 27216198
Nat Rev Cancer. 2006 Nov;6(11):857-66
pubmed: 17060945

Auteurs

Isabelle Flammang (I)

Department of General, Visceral and Transplantation Surgery, University Hospital Muenster, Albert-Schweitzer-Campus 1 (W1), 48149 Muenster, Germany.

Moritz Reese (M)

Department of General, Visceral and Transplantation Surgery, University Hospital Muenster, Albert-Schweitzer-Campus 1 (W1), 48149 Muenster, Germany.

Zixuan Yang (Z)

Department of General, Visceral and Transplantation Surgery, University Hospital Muenster, Albert-Schweitzer-Campus 1 (W1), 48149 Muenster, Germany.

Johannes A Eble (JA)

Department of Physiological Chemistry and Pathobiochemistry, University of Muenster, Waldeyerstrasse 15, 48149 Muenster, Germany.

Sameer A Dhayat (SA)

Department of General, Visceral and Transplantation Surgery, University Hospital Muenster, Albert-Schweitzer-Campus 1 (W1), 48149 Muenster, Germany.

Classifications MeSH